Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.

Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK.

Neurosurgery. 2012 Feb;70(2):361-70. doi: 10.1227/NEU.0b013e3182314f9d.

PMID:
21841523
[PubMed - indexed for MEDLINE]
2.

Impact of bevacizumab chemotherapy on craniotomy wound healing.

Clark AJ, Butowski NA, Chang SM, Prados MD, Clarke J, Polley MY, Sughrue ME, McDermott MW, Parsa AT, Berger MS, Aghi MK.

J Neurosurg. 2011 Jun;114(6):1609-16. doi: 10.3171/2010.10.JNS101042. Epub 2010 Dec 10.

PMID:
21142749
[PubMed - indexed for MEDLINE]
3.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
[PubMed - indexed for MEDLINE]
4.

Disseminated progression of glioblastoma after treatment with bevacizumab.

Bloch O, Safaee M, Sun MZ, Butowski NA, McDermott MW, Berger MS, Aghi MK, Parsa AT.

Clin Neurol Neurosurg. 2013 Sep;115(9):1795-801. doi: 10.1016/j.clineuro.2013.04.017. Epub 2013 May 21.

PMID:
23706614
[PubMed - indexed for MEDLINE]
5.

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N.

J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.

PMID:
24484232
[PubMed - indexed for MEDLINE]
6.

Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival.

Burkhardt JK, Riina H, Shin BJ, Christos P, Kesavabhotla K, Hofstetter CP, Tsiouris AJ, Boockvar JA.

World Neurosurg. 2012 Jan;77(1):130-4. doi: 10.1016/j.wneu.2011.05.056. Epub 2011 Nov 21.

PMID:
22405392
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

γ knife surgery versus reoperation for recurrent glioblastoma multiforme.

Skeie BS, Enger PØ, Brøgger J, Ganz JC, Thorsen F, Heggdal JI, Pedersen PH.

World Neurosurg. 2012 Dec;78(6):658-69. doi: 10.1016/j.wneu.2012.03.024. Epub 2012 Apr 4.

PMID:
22484078
[PubMed - indexed for MEDLINE]
8.

Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.

Subach BR, Witham TF, Kondziolka D, Lunsford LD, Bozik M, Schiff D.

Neurosurgery. 1999 Jul;45(1):17-22; discussion 22-3.

PMID:
10414561
[PubMed - indexed for MEDLINE]
9.

Multiple resections for patients with glioblastoma: prolonging survival.

Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2013 Apr;118(4):812-20. doi: 10.3171/2012.9.JNS1277. Epub 2012 Oct 19.

PMID:
23082884
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.

Park KJ, Kano H, Iyer A, Liu X, Niranjan A, Flickinger JC, Lieberman FS, Lunsford LD, Kondziolka D.

J Neurooncol. 2012 Apr;107(2):323-33. doi: 10.1007/s11060-011-0744-9. Epub 2011 Nov 5.

PMID:
22057917
[PubMed - indexed for MEDLINE]
11.

Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.

Hassaneen W, Levine NB, Suki D, Salaskar AL, de Moura Lima A, McCutcheon IE, Prabhu SS, Lang FF, DeMonte F, Rao G, Weinberg JS, Wildrick DM, Aldape KD, Sawaya R.

J Neurosurg. 2011 Mar;114(3):576-84. doi: 10.3171/2010.6.JNS091326. Epub 2010 Aug 6.

PMID:
20690813
[PubMed - indexed for MEDLINE]
12.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD; North American Brain Tumor Consortium.

Neuro Oncol. 2011 Oct;13(10):1118-24. doi: 10.1093/neuonc/nor110. Epub 2011 Aug 2.

PMID:
21813511
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.

Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS.

Neurosurgery. 1994 Sep;35(3):378-88; discussion 388.

PMID:
7800129
[PubMed - indexed for MEDLINE]
14.

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.

Iwamoto FM, Abrey LE, Beal K, Gutin PH, Rosenblum MK, Reuter VE, DeAngelis LM, Lassman AB.

Neurology. 2009 Oct 13;73(15):1200-6. doi: 10.1212/WNL.0b013e3181bc0184.

PMID:
19822869
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD.

Neurosurgery. 1997 Oct;41(4):776-83; discussion 783-5.

PMID:
9316038
[PubMed - indexed for MEDLINE]
16.

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.

Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG; Brain Cancer Register of the Fondazione IRCCS (Istituto Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta.

Neuro Oncol. 2008 Feb;10(1):79-87. Epub 2007 Nov 9.

PMID:
17993634
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.

Paldino MJ, Desjardins A, Friedman HS, Vredenburgh JJ, Barboriak DP.

Br J Radiol. 2012 Apr;85(1012):382-9. doi: 10.1259/bjr/24774491. Epub 2011 Jan 11.

PMID:
21224297
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.

Fabrini MG, Perrone F, De Franco L, Pasqualetti F, Grespi S, Vannozzi R, Cionini L.

Strahlenther Onkol. 2009 Aug;185(8):524-9. doi: 10.1007/s00066-009-1965-0. Epub 2009 Aug 4. Erratum in: Strahlenther Onkol. 2009 Oct;185(10):703.

PMID:
19652936
[PubMed - indexed for MEDLINE]
19.

The value of reoperation for recurrent glioblastoma.

Dirks P, Bernstein M, Muller PJ, Tucker WS.

Can J Surg. 1993 Jun;36(3):271-5.

PMID:
8391917
[PubMed - indexed for MEDLINE]
20.

Outcome of discontinuing bevacizumab prior to malignant glioma progression.

Sherman WJ, Raizer JJ, Grimm SA.

J Neurooncol. 2013 Jan;111(1):87-9. doi: 10.1007/s11060-012-0985-2. Epub 2012 Oct 12. No abstract available.

PMID:
23065093
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk